Contract with Customer, Liability, Noncurrent of VBI Vaccines Inc/BC from 31 Dec 2017 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
Summary
VBI Vaccines Inc/BC quarterly Contract with Customer, Liability, Noncurrent in USD history and change rate from 31 Dec 2017 to 31 Mar 2024.
  • VBI Vaccines Inc/BC Contract with Customer, Liability, Noncurrent for the quarter ending 31 Mar 2024 was $1,608,000, a 18% decline year-over-year.
Source SEC data
View on sec.gov
Contract with Customer, Liability, Noncurrent, Quarterly (USD)
Contract with Customer, Liability, Noncurrent, YoY Quarterly Change (%)

VBI Vaccines Inc/BC Quarterly Contract with Customer, Liability, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $1,608,000 -$353,000 -18% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $1,832,000 -$372,000 -17% 31 Dec 2023 10-Q 15 May 2024 2024 Q1
Q3 2023 $1,748,000 -$256,000 -13% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $1,793,000 -$85,000 -4.5% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $1,961,000 -$207,000 -9.5% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $2,204,000 -$73,000 -3.2% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 $2,004,000 -$536,000 -21% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $1,878,000 -$224,000 -11% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $2,168,000 +$50,000 +2.4% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $2,277,000 -$572,000 -20% 31 Dec 2021 10-K 13 Mar 2023 2022 FY
Q3 2021 $2,540,000 -$113,000 -4.3% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $2,102,000 -$424,000 -17% 30 Jun 2021 10-Q 02 Aug 2021 2021 Q2
Q1 2021 $2,118,000 -$455,000 -18% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $2,849,000 -$60,000 -2.1% 31 Dec 2020 10-K 07 Mar 2022 2021 FY
Q3 2020 $2,653,000 -$300,000 -10% 30 Sep 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 $2,526,000 -$24,000 -0.94% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $2,573,000 -$186,000 -6.7% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $2,909,000 +$112,000 +4% 31 Dec 2019 10-K 02 Mar 2021 2020 FY
Q3 2019 $2,953,000 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $2,550,000 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $2,759,000 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 $2,797,000 +$2,128,000 +318% 31 Dec 2018 10-K 05 Mar 2020 2019 FY
Q4 2017 $669,000 31 Dec 2017 10-K 25 Feb 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.